Saturday, 9 February 2013

EMA Begins Safety Review Of Acne Drug Diane 35

A safety review of the acne drug Diane 35 (cyproterone acetate 2 mg, ethinylestradiol 35µg) and its generics has officially begun. The review was started by The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) at its meeting February 4-7 2013... via Featured Health News from Medical News Today Read More Here..

No comments:

Post a Comment